|
ZNF711 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.30531174547377E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.65089997228307E-09 |
| Normal-vs-Stage2 |
4.14440004536942E-09 |
| Normal-vs-Stage3 |
8.32667268468867E-15 |
| Normal-vs-Stage4 |
1.50049972447164E-10 |
| Stage1-vs-Stage2 |
3.524000E-01 |
| Stage1-vs-Stage3 |
6.344300E-03 |
| Stage1-vs-Stage4 |
5.155900E-02 |
| Stage2-vs-Stage3 |
2.203000E-01 |
| Stage2-vs-Stage4 |
2.305000E-01 |
| Stage3-vs-Stage4 |
8.182400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.57860407973476E-11 |
| Normal-vs-AfricanAmerican |
4.758900E-03 |
| Normal-vs-Asian |
1.31139999970387E-08 |
| Caucasian-vs-AfricanAmerican |
4.546200E-01 |
| Caucasian-vs-Asian |
6.847800E-01 |
| AfricanAmerican-vs-Asian |
6.742000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.74130043717469E-10 |
| Normal-vs-Female |
2.26909602218939E-11 |
| Male-vs-Female |
7.871200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.01499997295917E-09 |
| Normal-vs-Age(41-60Yrs) |
5.50379741781626E-11 |
| Normal-vs-Age(61-80Yrs) |
6.60149712672364E-11 |
| Normal-vs-Age(81-100Yrs) |
4.300200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.130000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.044400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.328800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.151000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.449400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.680200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.60819999999573E-05 |
| Classical-VS-Follicular |
7.754800E-01 |
| Classical-VS-Other |
3.900400E-01 |
| Classical-VS-Normal |
9.23305876199265E-12 |
| Tall-VS-Follicular |
5.562800E-03 |
| Tall-VS-Other |
1.711380E-01 |
| Tall-VS-Normal |
2.23154827949656E-14 |
| Follicular-VS-Other |
3.713400E-01 |
| Follicular-VS-Normal |
7.72270000171105E-08 |
| Other-VS-Normal |
8.076600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.73740030642955E-10 |
| Normal-vs-N1 |
3.726099995216E-08 |
| N0-vs-N1 |
7.329400E-01 |
|
|
